Metabolic syndrome risk, monitoring and metformin after olanzapine (MEQ)

(i) Metabolic syndrome components. Cluster of central adiposity (waist), elevated triglycerides, low HDL-C, elevated blood pressure and elevated fasting glucose. NCEP-style teaching uses three or more components; IDF emphasises waist as a required entry criterion plus two further factors. This man already shows rapid central weight gain, rising glucose into the impaired range and hypertriglyceridaemia — a clear adverse cardiometabolic trajectory even if formal MetS criteria are still accruing.^[8][1]

(ii) Hierarchy and mechanisms. Olanzapine ranks with clozapine in the highest metabolic liability tier for weight, diabetes and dyslipidaemia. Mechanisms include H1 and 5-HT2C antagonism (appetite/satiety), reduced activity from sedation, and insulin-resistance/lipid pathway effects beyond kilograms alone.^[2][3][7]

(iii) Monitoring schedule. ADA/APA skeleton: baseline weight/BMI, waist, BP, fasting glucose/HbA1c and lipids; weight at 4, 8 and 12 weeks then quarterly; recheck glucose, lipids and BP at about 12 weeks and at least annually, sooner if rapid gain or symptoms. He should already have had the 4- and 8-week weight checks that detected this trajectory.^[1]

(iv) Immediate management. Shared decision; intensify lifestyle (diet, activity, sleep, smoking if relevant); consider switch to a lower-metabolic agent (e.g. aripiprazole) with cross-taper while psychosis remains controlled; consider metformin adjunct — teaching start 500 mg orally daily or twice daily with food, titrate toward 1000–2000 mg/day if eGFR allows, check contraindications and counsel GI effects (Wu; Jarskog METS). Treat emerging prediabetes/lipids with GP/endocrine standards; safety-net symptomatic hyperglycaemia.^[4][5][6][1]

(v) If clozapine were required for TRS. Do not automatically stop unique TRS efficacy for metabolic fear alone. Use intensive monitoring, lifestyle, metformin, cardiometabolic medicines and documented shared decision; coordinate physical health aggressively. Metabolic management becomes more intense rather than abandonment of the only highly effective agent.^[7][5]